resiquimod has been researched along with phosphoserine in 1 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (phosphoserine) | Trials (phosphoserine) | Recent Studies (post-2010) (phosphoserine) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 3,337 | 3 | 830 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibbs, BF; Pchejetski, D; Sumbayev, VV; Wyszynski, RW; Yasinska, IM | 1 |
1 other study(ies) available for resiquimod and phosphoserine
| Article | Year |
|---|---|
Differential control of hypoxia-inducible factor 1 activity during pro-inflammatory reactions of human haematopoietic cells of myeloid lineage.
Topics: Basophils; Cell Lineage; Congenital Disorders of Glycosylation; HEK293 Cells; Hematopoietic System; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Inflammation; Myeloid Cells; Nitric Oxide Synthase; Peptidoglycan; Phosphorylation; Phosphoserine; Signal Transduction; Toll-Like Receptors; TOR Serine-Threonine Kinases; Von Hippel-Lindau Tumor Suppressor Protein | 2012 |